A Comparative Evaluation of Pharmacokinetics and Immunogenicity.
NCT06918587
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
180
Enrollment
INDUSTRY
Sponsor class
Conditions
Febrile Neutropenia
Interventions
DEVICE:
TPI-120 with On body injector
DRUG:
Fylntera
Sponsor
Kashiv BioSciences, LLC